Journal
CLINICAL PHARMACOKINETICS
Volume 41, Issue 11, Pages 877-899Publisher
ADIS INT LTD
DOI: 10.2165/00003088-200241110-00005
Keywords
-
Categories
Ask authors/readers for more resources
The clinical development of new drugs is often terminated because of unfavourable pharmacokinetic properties such as poor intestinal absorption after oral administration. Intestinal permeability and solubility are two of the most important factors that determine the absorption properties of a compound. Efficient and reliable computational models that predict these properties as early as possible in drug discovery and development are therefore desirable. In this review, we first discuss the implementation of predictive models of intestinal drug permeability and solubility in drug discovery and development. Secondly, we discuss the mechanisms of intestinal drug permeability and computational methods that can be used to predict it. We then discuss factors influencing drug solubility and models for predicting it. We finally speculate that once these and other predictive computational models arc implemented in drug discovery and development, these processes will become much more effective. Further, an increased fraction of drug candidates that arc less likely to fail during clinical development will be selected.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available